Miltenyi Biomedicine

Develops innovative cell and gene therapies, including CAR T, CAR NK, and induced pluripotent stem cells, to provide cancer treatments and regenerative therapies to patients with unmet medical needs. Collaborates with healthcare providers to expand access to new therapies.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading